Belgravia Hartford and DelphX Collaboration Announcement
Belgravia Hartford Capital Inc. (CSE: BLGV) (OTC: BLGVF) (FRA: ECA) is excited to share the news of a new partnership with DelphX Capital Markets Inc. This strategic alliance aims to open the door for innovative financial solutions in the evolving landscape of cryptocurrency.
Details of the Non-Binding Letter of Intent
Under the terms of the non-binding letter of intent (the "LOI"), both parties are set to work together on the anticipated launch of the first commercial QCS transaction. This initiative represents an opportunity for Belgravia to be a pioneering corporate purchaser of a QCS collateralized put option, specifically designed to safeguard and maintain corporate Bitcoin treasury holdings. As the deal unfolds, it will undergo customary evaluations, including regulatory approvals and market assessments. There isn't a guarantee that this transaction will be finalized.
Support for Successful Implementation
Belgravia's role will involve providing advisory and structuring support to DelphX, which includes crucial tasks such as program documentation and compliance processes. The collaboration aims to ensure smooth onboarding and coordination with a designated placement agent. It’s essential to note that while the LOI is non-binding with the exception of confidentiality and regulatory compliance clauses, either party retains the right to terminate the agreement at any point.
Understanding DelphX Capital Markets Inc.
DelphX is at the forefront of innovation in the financial services sector, concentrating on the development of structured products. Through its dedicated special purpose vehicle, Quantem LLC, the firm empowers broker-dealers to offer unique securities that provide both fixed-income solutions and cryptocurrency-based opportunities. Among DelphX's portfolio of proprietary securities are:
Key Financial Instruments
- Collateralized Put Options (CPOs): These instruments deliver secured protection against potential downgrades of corporate bonds and losses associated with cryptocurrency holdings.
- Collateralized Reference Notes (CRNs): These notes allow investors to accept capped downgrade or cryptocurrency-loss exposure for the chance of attractive returns.
All CPOs and CRNs are fully collateralized, ensuring security as they are held in custody by a reputable financial institution. These unique products are meticulously crafted and owned by DelphX Capital Markets Inc.
Regulatory Considerations and Company Vision
The securities involved in this partnership have not been registered under the United States Securities Act of 1933, preventing them from being offered or sold within U.S. territory unless they comply with specific regulatory exemptions. It's important for investors to understand the limitations surrounding these transactions.
Belgravia Hartford Capital Inc. operates as an investment issuer, actively traded on the Canadian Securities Exchange. The company emphasizes its dedication to sectors within the tech and finance spheres of the cryptocurrency ecosystem, particularly Bitcoin. Its investment strategy, outlined in its 2018 Investment Policy, includes sectors like cryptocurrencies, artificial intelligence, media, and digital streaming. Through this diverse investment approach, Belgravia targets high-risk opportunities, which may lead to significant volatility and potential losses for shareholders.
Company Contact Information
For more information about Belgravia Hartford and its investment approach, interested parties can find details through the company's official communication channels. Please note that the company does not endorse unsolicited inquiries.
Frequently Asked Questions
What is the purpose of the LOI between Belgravia and DelphX?
The LOI aims to forge a collaboration for executing QCS transactions designed to protect Bitcoin treasury holdings.
What are Collateralized Put Options?
Collateralized Put Options (CPOs) are financial instruments that provide security against corporate bond downgrades and cryptocurrency losses.
Who is DelphX Capital Markets?
DelphX is a financial services company focused on creating structured products in collaboration with broker-dealers, offering innovative investment opportunities.
What risks are associated with Belgravia’s investment strategy?
Belgravia's strategy is considered high-risk, exposing shareholders to potential volatility and financial losses.
How does Belgravia support DelphX in this partnership?
Belgravia will provide advisory support, assist in compliance, and facilitate onboarding with a designated placement agent for the QCS launch.
